Patents Assigned to Biopharma Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka GmbH
  • Publication number: 20050026247
    Abstract: A process for preparing a purified refolded monomer or dimer of a bone-derived factor, which comprises subjecting an inclusion body of a bone-derived factor produced by genetic engineering to the following steps a) to c) in sequence: a) introducing a polynucleotide encoding a bone morphogenetic factor into a bacterium, expressing said bone morphogenetic factor in the form of an inclusion body, recovering said inclusion body and treating it with a denaturing agent to obtain a solubilized monomer, b) treating the solubilized monomer without purification directly with a refolding solution to obtain a refolded monomeric bone morphogenetic factor, c) subjecting the refolded monomeric bone morphogenetic factor to purification.
    Type: Application
    Filed: December 15, 2003
    Publication date: February 3, 2005
    Applicant: Biopharma Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka GmbH
    Inventors: Hidetoshi Andou, Jun Honda, Shunjiro Sugimoto, Gertrud Hotten, Rolf Bechtold, Jens Pohl